BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

482 related articles for article (PubMed ID: 17100967)

  • 1. Inflammation and coagulation in inflammatory bowel disease: The clot thickens.
    Danese S; Papa A; Saibeni S; Repici A; Malesci A; Vecchi M
    Am J Gastroenterol; 2007 Jan; 102(1):174-86. PubMed ID: 17100967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exploring the relationships between inflammatory response and coagulation cascade in inflammatory bowel disease.
    Saibeni S; Spina L; Vecchi M
    Eur Rev Med Pharmacol Sci; 2004; 8(5):205-8. PubMed ID: 15638231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarkers of altered coagulation and fibrinolysis as measures of disease activity in active inflammatory bowel disease: a gender-stratified, cohort analysis.
    Shen J; Ran ZH; Zhang Y; Cai Q; Yin HM; Zhou XT; Xiao SD
    Thromb Res; 2009 Feb; 123(4):604-11. PubMed ID: 18499234
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vascular involvement in inflammatory bowel disease: pathogenesis and clinical aspects.
    Papa A; Scaldaferri F; Danese S; Guglielmo S; Roberto I; Bonizzi M; Mocci G; Felice C; Ricci C; Andrisani G; Fedeli G; Gasbarrini G; Gasbarrini A
    Dig Dis; 2008; 26(2):149-55. PubMed ID: 18431065
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extraintestinal considerations in inflammatory bowel disease.
    Levine JB; Lukawski-Trubish D
    Gastroenterol Clin North Am; 1995 Sep; 24(3):633-46. PubMed ID: 8809240
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coagulation factor Xa signaling: the link between coagulation and inflammatory bowel disease?
    Borensztajn K; Peppelenbosch MP; Spek CA
    Trends Pharmacol Sci; 2009 Jan; 30(1):8-16. PubMed ID: 19058861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets in inflammatory bowel disease: clinical, pathogenic, and therapeutic implications.
    Danese S; Motte Cd Cde L; Fiocchi C
    Am J Gastroenterol; 2004 May; 99(5):938-45. PubMed ID: 15128364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular pathogenesis of inflammatory bowel disease: genotypes, phenotypes and personalized medicine.
    Goyette P; Labbé C; Trinh TT; Xavier RJ; Rioux JD
    Ann Med; 2007; 39(3):177-99. PubMed ID: 17457716
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inflammation and the mucosal microcirculation in inflammatory bowel disease: the ebb and flow.
    Danese S
    Curr Opin Gastroenterol; 2007 Jul; 23(4):384-9. PubMed ID: 17545773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PAI-1 and TAFI in inflammatory bowel disease: the yin and yang of the fibrinolytic system.
    Danese S; Papa A
    Eur J Gastroenterol Hepatol; 2008 Sep; 20(9):826-8. PubMed ID: 18794594
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hematologic aspects of inflammatory bowel diseases].
    Udvardy M; Altorjay I; Palatka K
    Orv Hetil; 2001 Apr; 142(17):883-6. PubMed ID: 11373889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune dysfunction in inflammatory bowel disease.
    Neuman MG
    Transl Res; 2007 Apr; 149(4):173-86. PubMed ID: 17383591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease in the pediatric patient.
    Ponsky T; Hindle A; Sandler A
    Surg Clin North Am; 2007 Jun; 87(3):643-58. PubMed ID: 17560417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
    Chidlow JH; Shukla D; Grisham MB; Kevil CG
    Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and experimental evidence of sympathetic neural dysfunction during inflammatory bowel disease.
    Boissé L; Chisholm SP; Lukewich MK; Lomax AE
    Clin Exp Pharmacol Physiol; 2009 Oct; 36(10):1026-33. PubMed ID: 19566829
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Newer aspects of inflammatory bowel disease and its cutaneous manifestations: a selective review.
    Apgar JT
    Semin Dermatol; 1991 Sep; 10(3):138-47. PubMed ID: 1931561
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of the vascular and lymphatic endothelium in the pathogenesis of inflammatory bowel disease: 'brothers in arms'.
    Danese S
    Gut; 2011 Jul; 60(7):998-1008. PubMed ID: 21212253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling for inflammation and repair in inflammatory bowel disease.
    Neuman MG
    Rom J Gastroenterol; 2004 Dec; 13(4):309-16. PubMed ID: 15624029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunology of inflammatory bowel diseases.
    Lakatos L
    Acta Physiol Hung; 2000; 87(4):355-72. PubMed ID: 11732889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.